Simplifying Global Compliance
Biomarkers for Drug-Induced Kidney Injury Get Boost From EMA, FDA
Clinical Trials Advisor
The European Medicines Agency is lending support to an initiative to qualify biomarkers that can provide early warning of an investigational compound’s risks of causing drug-induced kidney injuries.
To View This Article:
Subscribe To Clinical Trials Advisor
Copyright ©2019. All Rights Reserved.
Design, CMS, Hosting & Web Development :: ePublishing